Literature DB >> 3510141

The glucokinase glucose sensor in human pancreatic islet tissue.

F J Bedoya, J M Wilson, A K Ghosh, D Finegold, F M Matschinsky.   

Abstract

The enzyme glucokinase controls glucose metabolism in islets and is proposed to be the glucose sensor in pancreatic beta-cells. This concept was developed from studies with rodents and it remained to be explored whether it also applies to man. Studies in man were hampered, however, by the difficulty in obtaining well-preserved pancreatic islet tissue and also because the high activity of hexokinase made it difficult to measure glucokinase. To overcome these obstacles, quantitative histochemical sampling techniques were developed allowing precise dissection of pure human islet tissue and a newly designed radiometric microassay was used, avoiding hexokinase interference, and providing the sensitivity necessary to measure the relatively low glucokinase activity in small samples of tissue obtained from brain-dead tissue donors. The present data indicate that glucokinase is present in human pancreatic islet tissue and is not found in the exocrine pancreas. The enzyme's Vmax with D-glucose as substrate was similar to the Vmax for glucose utilization reported previously for intact, isolated human islets and the enzyme's Km for D-glucose was about 5 mM. Since glucokinase was also present in islet tissue of hamster, mouse, and rat, it is suggested that the glucokinase-glucose sensor concept has general applicability and that it could explain many aspects of the physiology and pathology of glucose homeostasis. This well-defined pancreatic islet glucokinase-glucose sensor should, therefore, be incorporated in any comprehensive model of glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510141     DOI: 10.2337/diab.35.1.61

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  Effect of biotin on glucokinase activity, mRNA expression and insulin release in cultured beta-cells.

Authors:  P Borboni; R Magnaterra; R A Rabini; R Staffolani; O Porzio; G Sesti; A Fusco; L Mazzanti; R Lauro; L N Marlier
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

Review 2.  Maternally inherited diabetes and deafness: a new diabetes subtype.

Authors:  J A Maassen; T Kadowaki
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 3.  Glucokinase as pancreatic beta cell glucose sensor and diabetes gene.

Authors:  F Matschinsky; Y Liang; P Kesavan; L Wang; P Froguel; G Velho; D Cohen; M A Permutt; Y Tanizawa; T L Jetton
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

4.  ATP-independent glucose stimulation of sphingosine kinase in rat pancreatic islets.

Authors:  L D Mastrandrea; S M Sessanna; A Del Toro; S G Laychock
Journal:  J Lipid Res       Date:  2010-04-05       Impact factor: 5.922

5.  Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.

Authors:  A De Vos; H Heimberg; E Quartier; P Huypens; L Bouwens; D Pipeleers; F Schuit
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents.

Authors:  Y Liang; S Bonner-Weir; Y J Wu; C D Berdanier; D K Berner; S Efrat; F M Matschinsky
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 7.  Assessing the potential of glucokinase activators in diabetes therapy.

Authors:  Franz M Matschinsky
Journal:  Nat Rev Drug Discov       Date:  2009-04-17       Impact factor: 84.694

Review 8.  Repair of diverse diabetic defects of β-cells in man and mouse by pharmacological glucokinase activation.

Authors:  Nicolai M Doliba; Deborah Fenner; Bogumil Zelent; Joseph Bass; Ramakanth Sarabu; Franz M Matschinsky
Journal:  Diabetes Obes Metab       Date:  2012-10       Impact factor: 6.577

9.  Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes.

Authors:  P B Iynedjian; S Marie; A Gjinovci; B Genin; S P Deng; L Buhler; P Morel; G Mentha
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

10.  Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells.

Authors:  Jean-Claude Henquin; Christine Sempoux; Joelle Marchandise; Sebastien Godecharles; Yves Guiot; Myriam Nenquin; Jacques Rahier
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.